TANG CAPITAL MANAGEMENT LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Bolt Biotherapeutics, Inc. Common Stock, par value $0.00001 per share (BOLT)

Filing Manager: TANG CAPITAL MANAGEMENT LLC
Reporting Manager: TANG CAPITAL MANAGEMENT, LLC
Security: Bolt Biotherapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol: BOLT
Shares outstanding: 38,512,859 shares
Disclosed Ownership: 3,812,773 shares
Ownership: 9.9%
Form type: SCHEDULE 13G/A
Filing time: 15 May 2025, 16:15:24 UTC
Date of event: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (6)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
TANG CAPITAL MANAGEMENT, LLC	9.9%	3,812,773	3,812,773	/s/ Kevin Tang	Manager
KEVIN TANG	9.9%	3,812,773	3,812,773	/s/ Kevin Tang	Self
TANG CAPITAL PARTNERS, LP	5.6%	2,145,517	2,145,517	/s/ Kevin Tang	Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP	4.3%	1,667,256	1,667,256	/s/ Kevin Tang	Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC	0%	0	0	Kevin Tang	Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC	0%	0	0	Kevin Tang	Chief Executive Officer